Table 1 Characteristics of NSCLC patients and quantification of Caspase-4 positive (+) vs Caspase-4 negative (−) tissues according to the histological score
From: Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
N. patients | Caspase-4 + | Caspase-4 - | |
|---|---|---|---|
Age | |||
≥ 60 yrs | 67 | 53 (79.1%) | 14 (20.9%) |
≤ 60 yrs | 22 | 15 (68.2%) | 7 (31.8%) |
Gender | |||
Male | 55 | 40 (72.7%) | 15 (27.3%) |
Female | 34 | 25 (73.5%) | 9 (26.4%) |
Stage I | 39 | 31 (79.5%) | 8 (20.5%) |
Stage II | 25 | 16 (64%) | 9 (36%) |
Stage III | 25 | 22 (88%) | 3 (12%) |
Hystotype | |||
Adenocarcinoma | 54 | 39 (72.2%) | 15 (27.8%) |
Squamous | 32 | 23 (71.9%) | 9 (28.1%) |
Other | 3 | 2 (66.6%) | 1 (33.4%) |